UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d)

of the Securities Exchange Act of 1934

Date of report (Date of earliest event reported): August 12 23, 2024

AUGMEDIX, INC.

(Exact name of registrant as specified in its charter)

Delaware		001-40890		83-3299164
(State or other jurisdiction of incorporation)		(Commission File Number)		(I.R.S. Employer Identification No.)

111 Sutter Street, Suite 1300, San Francisco, California 94104

(Address of principal executive offices) (Zip Code)

Registrant’s telephone number, including area code: (888) 669-4885

N/A

(Former name or former address, if changed since last report.)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) ☒☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) ☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) ☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:☒

Title of each class		Trading Symbol(s)		Name of each exchange on which registered
Common Stock, $0.0001 par value per share		AUGX		The Nasdaq Stock Market LLC

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☒

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Item 21.0201. Entry ~~Results~~into ofa ~~Operations~~Material ~~and~~Definitive ~~Financial Condition.~~Agreement

On August 12 23, 2024 (the “Effective Date”), Augmedix, ~~Inc~~Operating Corp., a Delaware corporation (f/k/a Augmedix, Inc., the “Company”), ~~released~~and ~~its~~subsidiary ~~financial~~of ~~results~~Augmedix, ~~for~~Inc., entered into an Eighth Omnibus Amendment (the ~~second~~“Amendment”) with ~~quarter~~Dignity ~~ended~~Health ~~June 30~~(“DH”), ~~2024.~~Dignity ~~The~~Health ~~press~~Medical ~~release~~Foundation ~~announcing~~(“DHMF”), and Pacific Central Coast Health Centers (“PHC”) to amend the ~~release~~statements of ~~financial~~work ~~results~~(the is“SOWs”) previously ~~furnished~~entered into between the Company and each of DH, DHMF and PHC pursuant to a Services Agreement, dated September 1, 2015, by and between the Company and CommonSpirit Health (f/k/a Catholic Health Initiative) (“CommonSpirit”), as ~~Exhibit~~successor-in-interest to 99Dignity Health (the “Agreement”).1 The Amendment extends the term of the SOWs through September 30, 2024 and ismemorializes the ~~incorporated~~intent ~~herein~~of bythe ~~reference~~Company and CommonSpirit to negotiate in good faith a new enterprise-wide agreement.

~~The~~A copy ~~information~~of ~~provided~~the inAmendment ~~this~~is ~~Item~~filed ~~2.02,~~as ~~including~~ Exhibit 9910.1, ~~is intended~~ to bethis ~~“furnished”~~Current ~~and~~Report ~~shall~~on ~~not~~Form 8-K beand ~~deemed~~is ~~“filed”~~incorporated ~~for~~herein ~~purposes~~by ofreference. ~~Section~~The 18foregoing description of the ~~Securities~~Amendment ~~Exchange~~does ~~Act~~not ofpurport ~~1934, as amended (the “Exchange Act”), or otherwise subject~~ to ~~the~~be ~~liabilities~~complete ofand ~~that~~is ~~section,~~qualified ~~nor~~in ~~shall~~its itentirety ~~be deemed incorporated~~ by reference ~~into~~to ~~any other filing under~~ the ~~Securities~~full ~~Act~~text of ~~1933, as amended, or~~ the ~~Exchange Act, except as expressly set forth by specific reference in such a filing~~Amendment.

Item 9.01. Financial Statements and Exhibits.

(d) Exhibits.

Exhibit No.	Description	~~Description~~
99.1		Press release dated August 12, 2024.
10.1	Eighth Omnibus Amendment, entered into on August 23, 2024, by and among Augmedix Operating Corp. f/k/a Augmedix, Inc., Dignity Health, Dignity Health Medical Foundation, and Pacific Central Coast Health Centers.
104	Cover Page Interactive Data File--the cover page XBRL tags are embedded within the Inline XBRL document.	~~Cover Page Interactive Data File--the cover page XBRL tags are embedded within the Inline XBRL document.~~

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

	AUGMEDIX, INC.		~~AUGMEDIX, INC.~~
Dated: August 12, 2024			By:	/s/ Paul Ginocchio
Dated: August 26, 2024	By:	/s/ Paul Ginocchio
		Paul Ginocchio		~~Paul Ginocchio~~
		Chief Financial Officer		~~Chief Financial Officer~~

Filing Compare · Augmedix, Inc.